Does Statin Therapy Reduce the Risks of Mortality and Major Adverse Cardiac and Cerebrovascular Events in Young Adults with End-Stage Renal Disease? Population-Based Cohort Study

Does Statin Therapy Reduce the Risks of Mortality and Major Adverse Cardiac and Cerebrovascular Events in Young Adults with End-Stage Renal Disease? Population-Based Cohort Study

Among hemodialysis patients aged more than 40 years old, previous large-scale studies showed statin treatment had no effect on reducing cardiovascular adverse events. However, young-adult-onset end-stage renal disease (ESRD) patients have different physicosocial factors compared to older ESRD patien...

Full description

Bibliographic Details
Main Authors: Ya-Lien Cheng, Huang-Yu Yang, Chao-Yi Wu, Chung-Ying Tsai, Chao-Yu Chen, Ching-Chung Hsiao, Hsiang-Hao Hsu, Ya-Chung Tian, Chieh-Li Yen
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
statin
dialysis
ESRD
young adult
cardiovascular
Online Access:https://www.mdpi.com/2077-0383/10/10/2097

Internet

https://www.mdpi.com/2077-0383/10/10/2097

Similar Items